Acupuncture help, harm, or placebo?
Meldrum et al. · Fertility and Sterility · 2013
Evidence Level
MODERATEOBJECTIVE
To reassess the efficacy of acupuncture as an adjunct treatment in IVF, questioning whether there is real benefit or only a placebo effect
WHO
Women undergoing in vitro fertilization (IVF)
DURATION
Analysis of studies published over 10 years
POINTS
Variable across included studies, with no standardization of acupuncture protocols
🔬 Study Design
Real Acupuncture
n=2500
True acupuncture with needle insertion
Diverse Controls
n=2500
Various controls including placebo (Streitberger) and no treatment
📊 Results in numbers
Pregnancy rate (original analysis)
Pregnancy rate (after study removal)
Live birth rate (Streitberger control)
Potential harmful effect
Percentage highlights
📊 Outcome Comparison
Clinical Pregnancy Rate
This study questions whether acupuncture truly helps women undergoing in vitro fertilization or whether the observed benefits are merely a placebo effect. Researchers found that when studies are analyzed with stricter criteria, the benefit of acupuncture disappears, and in some cases it may even be harmful.
Article summary
Plain-language narrative summary
This study is a critical reanalysis of the efficacy of acupuncture as an adjunct treatment in in vitro fertilization (IVF), fundamentally questioning whether the reported benefits are real or merely placebo effects. The authors, led by David Meldrum, reexamined a recent meta-analysis published in the same journal that included 23 studies with more than 5,000 participants.
The original work by Paulus et al. (2002) was the first to demonstrate a benefit of acupuncture in IVF, showing an odds ratio (OR) of 2.08 for clinical pregnancy. However, this study did not include an adequate placebo control, leaving open the possibility of a placebo effect. When the same researchers conducted a subsequent study with placebo control using Streitberger needles (which do not penetrate the skin), the benefit virtually disappeared.
In the current reanalysis, the authors identified significant methodological problems in the original meta-analysis. First, a non-randomized cohort study was included, violating basic criteria for high-quality meta-analyses. Second, three studies used inadequate controls with medications (alfentanil and lidocaine) that can directly affect oocytes and embryos. Third, some studies combined acupuncture with other therapies, such as Chinese herbal medicines, confounding the results.
When these problematic studies were removed and only pure acupuncture groups were analyzed, the odds ratio for clinical pregnancy fell to 1.14 (95% CI: 0.94-1.37), losing statistical significance. More concerning, when only studies with adequate placebo controls (Streitberger) were analyzed, the odds ratio was 0.89, suggesting an absence of benefit.
A particularly alarming finding was that three studies with Streitberger control showed a significant reduction in live birth rate (OR 0.74; 95% CI: 0.58-0.95), suggesting a potential harmful effect of acupuncture. Two individual studies showed statistically significant results with OR less than 1, indicating that acupuncture may, in certain circumstances, be harmful.
The authors propose that acupuncture may be harmful when applied aggressively, in patients unfamiliar with the treatment, or when it causes additional stress during critical moments of the IVF cycle. This is particularly relevant considering that stress can negatively affect reproductive outcomes.
The paper also addresses the question of placebo effects on 'objective' outcomes such as pregnancy. Contrary to popular belief, studies show that placebo effects can influence objective physical outcomes, not just subjective symptoms. The therapeutic environment, team expectations, and overall treatment experience can contribute to significant placebo effects.
The clinical implications are important. The authors suggest that patients should be informed about the current scientific uncertainty. If they choose acupuncture, they should be familiar with the treatment and the practitioner before the IVF cycle, and the procedure should be relaxing rather than stressful.
The study concludes that much larger and better-controlled clinical trials are needed to definitively determine whether acupuncture has real benefit beyond placebo. To detect a 10% increase in live birth rate, 3,829 participants would be needed in each group, requiring multicenter studies or multiple meta-analyses of smaller, uniformly designed studies.
Strengths
- 1Methodologically rigorous reanalysis of an existing meta-analysis
- 2Clear identification of methodological problems in included studies
- 3Large sample size (>5,000 participants)
- 4Balanced discussion of potential risks and benefits
- 5Clear practical guidance for clinicians
Limitations
- 1Not a primary study, but a reanalysis of existing data
- 2Significant heterogeneity between acupuncture protocols across studies
- 3Limited data on potential adverse effects
- 4Need for much larger future studies for definitive conclusions
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
The practice of acupuncture as an adjunct in in vitro fertilization cycles has become widespread over the past two decades, largely driven by early meta-analyses pointing to significant benefit. This work by Meldrum and colleagues directly challenges that narrative by reprocessing the same data with sharper methodological criteria, revealing that the apparent 22% gain in pregnancy rates dissolves once studies with inadequate controls are removed from the analysis. For the physician caring for couples in assisted reproduction treatment, this changes the office conversation: acupuncture can be offered as a complementary support resource for well-being, but not as an intervention with proven impact on live birth rates. Anxious populations, with previous failed cycles and high expectations for the procedure, deserve transparent guidance about the actual state of the evidence before agreeing to treatment.
▸ Notable Findings
The most disturbing finding of this reanalysis is not the absence of benefit, but the signal of potential harm: in the three studies that used Streitberger control — considered the gold-standard placebo in acupuncture — the odds ratio for live births was 0.74 (95% CI: 0.58–0.95), indicating a 26% reduction in this outcome. This result completely overturns the logic of 'at the very least it does no harm.' The hypothesis proposed by the authors is biologically plausible: acupuncture applied aggressively or in unprepared patients can trigger an autonomic stress response at a critical moment of the cycle, with potential impact on the endometrium and embryo receptivity. It is also striking that the original Paulus study, the foundation of all subsequent literature, never had an adequate placebo control — a detail that went years without receiving the weight it deserved.
▸ From My Experience
In my practice at the HC-FMUSP Pain Center, I rarely see patients in active IVF protocols, but I frequently receive women who arrive after failed cycles wanting to integrate acupuncture into the next attempt. What this work confirms is what I have observed empirically: the relational context and the patient's level of comfort with the procedure matter as much as the chosen point. When acupuncture is introduced on the eve of embryo transfer, with the patient having no prior familiarity with needles, the stressogenic potential outweighs any theoretical benefit. I usually advise that, if the patient wishes to integrate acupuncture into the reproductive cycle, the ideal is to start treatment at least two to three months in advance, establishing rapport and a consistent relaxation response. Profiles that respond best are those with an evident component of somatic tension, sleep disturbance, and associated dysmenorrhea — where the autonomic effect of acupuncture operates on receptive ground, regardless of the final reproductive outcome.
Full original article
Read the full scientific study
Fertility and Sterility · 2013
DOI: 10.1016/j.fertnstert.2012.12.046
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories